RISK FACTORS FOR THE DEVELOPMENT OF ENDOMETRIAL HYPERPLASTIC PROCESSES IN WOMEN WITH UTERINE FIBROIDS
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Despite the progress achieved in studying the etiopathogenesis, as well as in developing new diagnostic and therapeutic methods for endometrial hyperplastic processes (EHP), the problem of treating patients with this pathology still remains far from being fully resolved. This necessitates optimization of management strategies for patients with EHP during the menopausal transition period (MTP), which should be aimed not only at creating adequate comprehensive approaches for predicting the development and recurrence of endometrial hyperplasia (EH), but also at developing unified protocols for managing patients with this pathology.
Fields of Study & Subjects
Endometrial and Cervical Cancer Treatments
Uterine Myomas and Treatments
Gynecological conditions and treatments
Publication details
- Journal / source
- Экономика и социум
- Publication date
- 1 January 2026
- Language
- EN